Gross Margin: A company's total sales revenue minus its cost of goods sold, divided by the total sales revenue, expressed as a percentage. Calculated as: Gross Income / Total Revenues
Sonoma Pharmaceuticals, Inc. (SNOA) had Gross Margin of 39.22% for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
$5.56M |
|
$-0.58M |
|
$3.38M |
|
$2.18M |
|
$5.91M |
|
$-0.35M |
|
$-0.15M |
|
$-0.50M |
|
$-0.50M |
|
$-0.58M |
|
$-0.58M |
|
$-0.58M |
|
$-0.58M |
|
$-0.35M |
|
$-0.32M |
|
1.68M |
|
1.68M |
|
$-0.33 |
|
$-0.33 |
|
| Balance Sheet Financials | |
$12.10M |
|
$0.31M |
|
$1.86M |
|
$13.96M |
|
$4.83M |
|
-- |
|
$6.03M |
|
$10.87M |
|
$3.10M |
|
$3.10M |
|
$3.10M |
|
1.80M |
|
| Cash Flow Statement Financials | |
$-3.93M |
|
$-0.19M |
|
$0.48M |
|
$5.37M |
|
$2.40M |
|
$-2.98M |
|
$0.26M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.50 |
|
-- |
|
-- |
|
-- |
|
0.07 |
|
|
Gross Margin |
39.22% |
-6.31% |
|
-6.31% |
|
-- |
|
-8.94% |
|
-10.45% |
|
$-4.12M |
|
-- |
|
-- |
|
-- |
|
0.40 |
|
0.93 |
|
2.20 |
|
40.90 |
|
-18.77% |
|
-18.77% |
|
-4.16% |
|
-18.77% |
|
$1.72 |
|
$-2.45 |
|
$-2.34 |
|